STABILITY OF ACTIONABLE MUTATIONS IN PRIMARY AND RECURRENT GLIOBLASTOMAS

被引：0

作者：

French, P. J. ^{[1
]}

Taphoorn, M. ^{[2
]}

Weyerbrock, A. ^{[3
]}

Sanson, M. ^{[4
]}

Hoeben, A. ^{[5
]}

Lukavoca, S. ^{[6
]}

Lombardi, G. ^{[7
]}

Hanse, M. ^{[8
]}

Watts, C. ^{[9
]}

Golfinopoulos, V. ^{[10
]}

McDermott, U. ^{[11
]}

Robe, P. ^{[12
,13
]}

机构：

[1] Erasmus MC Hersentumorctr, Rotterdam, Netherlands

[2] MC Haaglanden, The Hague, Netherlands

[3] Univ Klinikum, Freiburg, Germany

[4] Hop Univ Pitie Salpetriere, Paris, France

[5] Maastricht UMC, Maastricht, Netherlands

[6] Aarhus Univ Hosp, Aarhus, Denmark

[7] Veneto Inst Oncol, Padua, Italy

[8] Elizabeth Hosp, Tilburg, Netherlands

[9] Addenbrookes Hosp, Cambridge, England

[10] EORTC Headquarters, Brussels, Belgium

[11] Wellcome Trust Sanger Inst, Hinxton, England

[12] UMC Utrecht, Utrecht, Netherlands

[13] CHU, Liege, Belgium

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P01.12

引用

页码：25 / 26

页数：2

共 50 条

[1] STABILITY OF ACTIONABLE MUTATIONS IN PRIMARY AND RECURRENT GLIOBLASTOMAS
Draaisma, K.
Taphoorn, M.
Weyerbrock, A.
Sanson, M.
Gorlia, T.
Golfinopoulos, V.
Kros, J. M.
Robe, P. A.
van den Bent, M. M. J.
French, J.
[J]. NEURO-ONCOLOGY, 2016, 18 : 12 - 12
[2] STABILITY OF ACTIONABLE MUTATIONS IN PRIMARY AND RECURRENT GLIOBLASTOMAS
Draaisma, Kaspar
Chatzipli, Aikaterini
Taphoorn, Martin
Kerkhof, Melissa
Weyerbrock, Astrid
Sanson, Marc
Hoeben, Ann
Slavka, Lukacova
Lombardi, Giuseppe
Hanse, Monique
Fleischeuer, Ruth
Leenstra, Sieger
Watts, Colin
Gorlia, Thierry
Golfinopoulos, Vassilis
Kros, Johan
van den Bent, Martin
McDermott, Ultan
Robe, Pierre
French, Pim
[J]. NEURO-ONCOLOGY, 2017, 19 : 92 - 92
[3] Identifying novel recurrent mutations reveals candidate actionable mutations
Chang, Matthew T.
Gao, Sizhi Paul
Bhattarai, Tripti Shrestha
Shamu, Tambudzai
Kandoth, Cyriac
Asthana, Saurabh
Chapman, Jocelyn S.
Gao, JianJiong
Socci, Nicholas D.
Olshen, Adam B.
Hyman, David M.
Berger, Michael F.
Solit, David B.
Schultz, Nikolaus D.
Taylor, Barry S.
[J]. CANCER RESEARCH, 2016, 76
[4] Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas
Petterson, Stine Asferg
Sorensen, Mia Dahl
Kristensen, Bjarne Winther
[J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (09): : 975 - 985
[5] Multi-Gene Sequencing Reveals Actionable Mutations in Primary and Recurrent Phyllodes Tumours of the Breast
Tan, Puay Hoon
Nasir, Nur Diyana Md
Ng, Cedric
Lim, Abner
Lee, Jing Yi
Lim, Boon Yee
Kannan, Bavani
Thike, Aye Aye
Koh, Valerie Cui Yun
Shi, Ruoyu
Gudi, Mihir
Rakha, Emad
Ko, Tun Kiat
Chan, Jason Yongsheng
Teh, Bin Tean
[J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S276 - S276
[6] TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi
Takashi Ohta
Ji-Eun Oh
Young-Ho Kim
Paul Kleihues
Hiroko Ohgaki
[J]. Acta Neuropathologica, 2013, 126 : 931 - 937
[7] TERT promoter mutations in primary and secondary glioblastomas
Nonoguchi, Naosuke
Ohta, Takashi
Oh, Ji-Eun
Kim, Young-Ho
Kleihues, Paul
Ohgaki, Hiroko
[J]. ACTA NEUROPATHOLOGICA, 2013, 126 (06) : 931 - 937
[8] CHEK2 mutations in primary glioblastomas
Sallinen, SL
Ikonen, T
Haapasalo, H
Schleutker, J
[J]. JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (01) : 93 - 95
[9] CHEK2 mutations in primary glioblastomas
Satu-Leena Sallinen
TarjaI konen
Hannu Haapasalo
Johanna Schleutker
[J]. Journal of Neuro-Oncology, 2005, 74 : 93 - 95
[10] Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches
Ellis, H. P.
McInerney, C. E.
Schrimpf, D.
Sahm, F.
Stupnikov, A.
Wadsley, M.
Wragg, C.
White, P.
Prise, K. M.
McArt, D. G.
Kurian, K. M.
[J]. JOURNAL OF ONCOLOGY, 2019, 2019

← 1 2 3 4 5 →